SCHEMBL14242540

SCHEMBL14242540

COc1cccc(N(C)c2cc(NC3CC3)n3ncc(/C=C(\NC=O)C(N)=O)c3n2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2B P67870 2/20 0.37
MTNR1A P48039 4/20 0.36
MTNR1B P49286 4/20 0.36
CSNK2A1 P68400 2/20 0.35
MCHR1 Q99705 1/20 0.35
TYK2 P29597 2/20 0.35
CCNT1 O60563 1/20 0.35
CDK9 P50750 1/20 0.35
PDE4B Q07343 3/20 0.34
PDE4D Q08499 2/20 0.34
BRAF P15056 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4C Q08493 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
ADORA2A P29274 1/20 0.33
CSNK2A2 P19784 1/20 0.33
PIM1 P11309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14243124 0.78 CSNK2B (0.48) CSNK2BCSNK2A1TYK2CCNT1CDK9
SCHEMBL18405391 0.78 CSNK2B (0.35) CSNK2BMTNR1AMTNR1BCSNK2A1MCHR1
SCHEMBL12644496 0.77 POLB (0.39) CSNK2BMTNR1AMTNR1BCSNK2A1MCHR1
SCHEMBL19526952 0.77 ADORA2A (0.36) CSNK2BMTNR1AMTNR1BCSNK2A1MCHR1
SCHEMBL14242545 0.76 CSNK2A1 (0.41) CSNK2BCSNK2A1TYK2CCNT1CDK9
SCHEMBL14243294 0.74 CSNK2B (0.45) CSNK2BCSNK2A1TYK2MEN1NPC1
SCHEMBL14243301 0.73 CSNK2B (0.48) CSNK2BCSNK2A1TYK2PDE4DCSNK2A2
SCHEMBL14242539 0.71 CSNK2B (0.44) CSNK2BCSNK2A1TYK2MEN1NPC1
SCHEMBL14242542 0.70 CSNK2B (0.40) CSNK2BCSNK2A1
SCHEMBL19527149 0.69 MLNR (0.38) CSNK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012170827-A2 PYRAZOLOPYRIMIDINES AND RELATED HETEROCYCLES AS CK2 INHIBITORS CYLENE PHARMACEUTICALS, INC. (US) 2012-12-13 WO disclosed